<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0025">
 <label>Table 5</label>
 <caption>
  <p>Details of seroneutralization testing.</p>
 </caption>
 <alt-text id="at0040">Table 5</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Reference</th>
    <th align="left">Country sampling</th>
    <th align="left">Country testing</th>
    <th align="left">Technique</th>
    <th align="left">JEV Strain</th>
    <th align="left">Other viruses tested</th>
    <th align="left">Cells</th>
    <th align="left">Virus Dose</th>
    <th align="left">End-point</th>
    <th align="left">Samples tested</th>
    <th align="left">Algorithm for seroneutralisation</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <xref rid="bib0655" ref-type="bibr">Sabin et al. (1947a</xref>)
    </td>
    <td align="left">Republic of Korea</td>
    <td align="left">Japan</td>
    <td align="left">Mice inoculation</td>
    <td align="left">G3 (Nakayama), human brain, Tokyo, Japan, 1935 (EF571853)</td>
    <td align="left">NR</td>
    <td align="left">Intracerebral and intraperitoneal inoculation in mice</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum, and CSF</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0660" ref-type="bibr">Sabin et al. (1947b</xref>)
    </td>
    <td align="left">China</td>
    <td align="left">Japan</td>
    <td align="left">Mice inoculation</td>
    <td align="left">G3 (Nakayama), human brain, Tokyo, Japan, 1935 (EF571853)</td>
    <td align="left">NR</td>
    <td align="left">Intracerebral and intraperitoneal</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum, and CSF</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0650" ref-type="bibr">Sabin (1947</xref>)
    </td>
    <td align="left">Japan</td>
    <td align="left">Japan</td>
    <td align="left">Mice inoculation</td>
    <td align="left">G3 (Nakayama), human brain, Tokyo, Japan, 1935 (EF571853)</td>
    <td align="left">NR</td>
    <td align="left">Intracerebral and intraperitoneal</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum, and CSF</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0240" ref-type="bibr">Edelman and Pariyanonda (1973</xref>)
    </td>
    <td align="left">Vietnam</td>
    <td align="left">Vietnam</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">DENV</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0070" ref-type="bibr">Benenson et al. (1975b</xref>)
    </td>
    <td align="left">Thailand</td>
    <td align="left">Thailand</td>
    <td align="left">PRNT</td>
    <td align="left">G3 strain (Nakayama), human brain, Tokyo, Japan, 1935 (EF571853)</td>
    <td align="left">DENV 4</td>
    <td align="left">LLC-MK2 cells</td>
    <td align="left">50-100 PFU</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0350" ref-type="bibr">Hoke et al. (1988</xref>)
    </td>
    <td align="left">Thailand</td>
    <td align="left">Thailand</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0140" ref-type="bibr">Cardosa et al. (1991</xref>)
    </td>
    <td align="left">Malaysia</td>
    <td align="left">Malaysia</td>
    <td align="left">PRNT</td>
    <td align="left">G3 strain (Nakayama), human brain, Tokyo, Japan, 1935 (EF571853)</td>
    <td align="left">DENV 2 (16681 strain)</td>
    <td align="left">
     <italic>Aedes albopictus</italic> C6/36 cells
    </td>
    <td align="left">NR</td>
    <td align="left">50%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">Confirmatory testing after positive MAC-ELISA</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0575" ref-type="bibr">Peiris et al. (1992</xref>)
    </td>
    <td align="left">Sri Lanka</td>
    <td align="left">Sri Lanka</td>
    <td align="left">Microtitre VNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Porcine stable (PS) kidney cells</td>
    <td align="left">NR</td>
    <td align="left">80%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Serum (NR if acute and/or f/up)</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0815" ref-type="bibr">Wittesjo et al. (1995</xref>)
    </td>
    <td align="left">Indonesia</td>
    <td align="left">Sweden</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">80%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0335" ref-type="bibr">Hennessy et al. (1996</xref>)
    </td>
    <td align="left">China</td>
    <td align="left">U.S.A.</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">CSF, Acute and f/up serum</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0215" ref-type="bibr">Desai et al. (1997b</xref>)
    </td>
    <td align="left">India</td>
    <td align="left">India</td>
    <td align="left">Microtitre VNT</td>
    <td align="left">G3 (P20778/P20), human brain, Vellore, India, 1958 (AF080251)</td>
    <td align="left">NR</td>
    <td align="left">Porcine stable (PS) kidney cells</td>
    <td align="left">100 TCID 50</td>
    <td align="left">100%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">CSF</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0675" ref-type="bibr">Saito et al. (1999c</xref>)
    </td>
    <td align="left">Japan</td>
    <td align="left">Japan</td>
    <td align="left">FRNT</td>
    <td align="left">NR</td>
    <td align="left">YFV</td>
    <td align="left">BHK-21 cells</td>
    <td align="left">NR</td>
    <td align="left">50%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">CSF, Acute and f/up serum</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0755" ref-type="bibr">Tiroumourougane et al. (2003</xref>)
    </td>
    <td align="left">India</td>
    <td align="left">India</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0200" ref-type="bibr">Cutfield et al. (2005</xref>)
    </td>
    <td align="left">China</td>
    <td align="left">New Zealand</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0170" ref-type="bibr">CDC (2005</xref>)
    </td>
    <td align="left">Thailand</td>
    <td align="left">U.S.A.</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0555" ref-type="bibr">Ompusunggu et al. (2008</xref>)
    </td>
    <td align="left">Indonesia</td>
    <td align="left">Indonesia</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Serum (NR if acute and/or convalescent)</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0470" ref-type="bibr">Lehtinen et al. (2008</xref>)
    </td>
    <td align="left">Thailand</td>
    <td align="left">Finland</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">DENV 2</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0610" ref-type="bibr">Ravi et al. (2009</xref>)
    </td>
    <td align="left">India</td>
    <td align="left">India</td>
    <td align="left">PRNT</td>
    <td align="left">ChimeriVax™-JEV</td>
    <td align="left">ChimeriVax™-DENV 2</td>
    <td align="left">Vero cells</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">CSF</td>
    <td align="left">Confirmatory testing after positive or equivocal MAC-ELISA</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0765" ref-type="bibr">Touch et al. (2009b</xref>)
    </td>
    <td align="left">Cambodia</td>
    <td align="left">Cambodia</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Vero cells</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0025" ref-type="bibr">Anga et al. (2010</xref>)
    </td>
    <td align="left">Papua New Guinea</td>
    <td align="left">Australia</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0355" ref-type="bibr">Hossain et al. (2010</xref>)
    </td>
    <td align="left">Bangladesh</td>
    <td align="left">U.S.A.</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">90%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0175" ref-type="bibr">CDC (2011</xref>)
    </td>
    <td align="left">U.S.A. (Travellers from the Philippines and Thailand)</td>
    <td align="left">U.S.A.</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">CSF</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0090" ref-type="bibr">Borah et al. (2011b</xref>)
    </td>
    <td align="left">India</td>
    <td align="left">India</td>
    <td align="left">Microtitre VNT</td>
    <td align="left">G3 strain (P20778/P20), human brain, Vellore, India, 1958 (AF080251)</td>
    <td align="left">NR</td>
    <td align="left">BHK-21 cells</td>
    <td align="left">100 TCID50 in 50 μL</td>
    <td align="left">50%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">Patients with paired serum available after MAC-ELISA tested</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0465" ref-type="bibr">Lee et al. (2012</xref>)
    </td>
    <td align="left">Republic of Korea</td>
    <td align="left">Republic of Korea</td>
    <td align="left">NR</td>
    <td align="left">Not reported</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and convalescent serum</td>
    <td align="left">Confirmatory testing after positive MAC-ELISA/HI/IIF.</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0455" ref-type="bibr">Langevin et al. (2012b</xref>)
    </td>
    <td align="left">Canada (Traveller from Thailand)</td>
    <td align="left">Canada</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">WNV and DENV</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">CSF, Acute and convalescent serum</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0345" ref-type="bibr">Hills et al. (2014</xref>)
    </td>
    <td align="left">China, Taiwan, Republic of Korea</td>
    <td align="left">U.S.A.</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0035" ref-type="bibr">Anukumar et al. (2014b</xref>)
    </td>
    <td align="left">India</td>
    <td align="left">India</td>
    <td align="left">Microtitre VNT</td>
    <td align="left">G3 (P3), human brain, Bankura, India, 1973 (AB379813/Z34095)</td>
    <td align="left">WNV</td>
    <td align="left">Porcine stable (PS) kidney cells</td>
    <td align="left">100 TCID50</td>
    <td align="left">50%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Acute serum</td>
    <td align="left">All acute serum</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0615" ref-type="bibr">Rayamajhi et al. (2015</xref>)
    </td>
    <td align="left">Nepal</td>
    <td align="left">U.S.</td>
    <td align="left">PRNT</td>
    <td align="left">NR</td>
    <td align="left">DENV, WNV, and Powassan viruses.</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">Confirmatory testing after positive or equivocal MAC-ELISA</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0680" ref-type="bibr">Saito et al. (2015</xref>)
    </td>
    <td align="left">Laos</td>
    <td align="left">Japan</td>
    <td align="left">FRNT</td>
    <td align="left">Nakayama (a pathogenic and vaccine strain, Tokyo, Japan, human brain, 1935, G3), Beijing-1 (a pathogenic and vaccine strain, Beijing, China, human brain, 1949, G3), P19-Br (an isolate, Chiang Mai, Thailand, human brain, 1982, G1), LaVS56 (an isolate, Vientiane, Lao PDR, swine sera, 1993, G1), and LaVS145 (an isolate, Vientiane, Lao PDR, swine sera, 1993, G1)</td>
    <td align="left">DENV 1 (Hawaiian), 2 (New Guinea B), 3 (H-87), and 4 (H-241) and WNV</td>
    <td align="left">BHK-21 cells</td>
    <td align="left">NR</td>
    <td align="left">50%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">All samples</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0480" ref-type="bibr">Li et al. (2016</xref>)
    </td>
    <td align="left">China</td>
    <td align="left">China</td>
    <td align="left">PRNT</td>
    <td align="left">G3 strain (733913), human brain, Beijing, China, 1949 (AY243805/AY243844)</td>
    <td align="left">NR</td>
    <td align="left">BHK-21 cells</td>
    <td align="left">100 PFUs</td>
    <td align="left">90%
     <xref rid="tblfn0020" ref-type="table-fn">*</xref>
    </td>
    <td align="left">Acute and f/up serum</td>
    <td align="left">All serum</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0730" ref-type="bibr">Sunwoo et al. (2016</xref>)
    </td>
    <td align="left">Republic of Korea</td>
    <td align="left">Republic of Korea</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="bib0440" ref-type="bibr">Kyaw et al. (2019</xref>)
    </td>
    <td align="left">Myanmar</td>
    <td align="left">Myanmar</td>
    <td align="left">FRNT and PRNT</td>
    <td align="left">G3 strain (JaOrS982), mosquitos, Japan, 1982 (NC_001437)</td>
    <td align="left">DENV 1-4</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">NR</td>
    <td align="left">CSF</td>
    <td align="left">NR</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>G1 and 3 = genotype 1 and 3; NR = not reported; CSF = cerebrospinal fluid; PRNT = plaque reduction neutralization test; DENV = Dengue virus; VNT = viral neutralization test; FRNT = focus reduction neutralization test; TCID = median tissue culture infectious dose.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tblfn0020">
   <label>*</label>
   <p id="npar0020">titer required to reduce dengue viral plaques/focus/CPE by 50%, 80%, or 90%. MAC-ELISA = IgM antibody capture enzyme-linked immunosorbent assay, HI = haemagglutination assay, IIF = Indirect immunofluorescence assay.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
